Piera La Cava

774 total citations
36 papers, 634 citations indexed

About

Piera La Cava is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Piera La Cava has authored 36 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 18 papers in Hematology and 14 papers in Oncology. Recurrent topics in Piera La Cava's work include Immune cells in cancer (16 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Acute Myeloid Leukemia Research (7 papers). Piera La Cava is often cited by papers focused on Immune cells in cancer (16 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Acute Myeloid Leukemia Research (7 papers). Piera La Cava collaborates with scholars based in Italy, United States and France. Piera La Cava's co-authors include Daniele Tibullo, Cesarina Giallongo, Francesco Di Raimondo, Nunziatina Laura Parrinello, Giuseppe A. Palumbo, Alessandra Romano, Fabio Stagno, Annalisa Chiarenza, Concetta Conticello and Ignazio Barbagallo and has published in prestigious journals such as Blood, PLoS ONE and British Journal of Haematology.

In The Last Decade

Piera La Cava

33 papers receiving 632 citations

Peers

Piera La Cava

IMMUN

HEMAT

ONCOL

GENET

Siamak Jabbarzadeh‐Tabrizi Japan

Karen-Sue Carlson United States

Christine Ragu France

Rana Baraz Australia

Theodore M. Duffy United States

Laura Barreyro United States

Philip E. Boulais United States

José‐Marc Techner United States

Kaniel Cassady United States

Brooke Snetsinger Canada

Siamak Jabbarzadeh‐Tabrizi Japan

Piera La Cava

252 ×0.9

IMMUN

247 ×1.0

HEMAT

314 ×1.4

172 ×0.8

ONCOL

99 ×0.8

GENET

Citations per year, relative to Piera La Cava Piera La Cava (= 1×) peers Siamak Jabbarzadeh‐Tabrizi

Countries citing papers authored by Piera La Cava

Since Specialization

Citations

This map shows the geographic impact of Piera La Cava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piera La Cava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piera La Cava more than expected).

Fields of papers citing papers by Piera La Cava

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piera La Cava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piera La Cava. The network helps show where Piera La Cava may publish in the future.

Co-authorship network of co-authors of Piera La Cava

This figure shows the co-authorship network connecting the top 25 collaborators of Piera La Cava. A scholar is included among the top collaborators of Piera La Cava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piera La Cava. Piera La Cava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Romano, Alessandra, Nunziatina Laura Parrinello, Annalisa Chiarenza, et al.. (2019). Immune off‐target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma. British Journal of Haematology. 185(3). 468–479. 19 indexed citations

Tirrò, Elena, Michele Massimino, Chiara Romano, et al.. (2019). Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53. Frontiers in Oncology. 9. 57–57. 26 indexed citations

Giallongo, Cesarina, Daniele Tibullo, Nunziatina Laura Parrinello, et al.. (2017). Mesenchymal Stromal Cells (MSC) As Key Players in the Tumor Microenvironment Transformation from MGUS to Myeloma. Blood. 130. 4361–4361. 1 indexed citations

Romano, Alessandra, Cesarina Giallongo, Piera La Cava, et al.. (2017). Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia. Frontiers in Pharmacology. 8. 204–204. 19 indexed citations

Romano, Alessandra, Nunziatina Laura Parrinello, Calogero Vetro, et al.. (2016). The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma. Oncotarget. 7(41). 67333–67346. 27 indexed citations

Tibullo, Daniele, Michelino Di Rosa, Cesarina Giallongo, et al.. (2015). Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells. Frontiers in Pharmacology. 6. 226–226. 17 indexed citations

Vetro, Calogero, Alessandra Romano, Francesco Coppolino, et al.. (2015). Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells. Frontiers in Oncology. 5. 104–104. 8 indexed citations

Giallongo, Cesarina, Nunziatina Laura Parrinello, Maria Violetta Brundo, et al.. (2015). Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia. Frontiers in Oncology. 5. 107–107. 31 indexed citations

Giallongo, Cesarina, Nunziatina Laura Parrinello, Daniele Tibullo, et al.. (2014). Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity Together with Polymorphonuclear Leukocytes (PMNs) in Chronic Myeloid Leukemia Patients. PLoS ONE. 9(7). e101848–e101848. 67 indexed citations

10.

Giallongo, Cesarina, Piera La Cava, Daniele Tibullo, et al.. (2013). SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation. BMC Cancer. 13(1). 60–60. 15 indexed citations

11.

Tibullo, Daniele, Ignazio Barbagallo, Cesarina Giallongo, et al.. (2013). Nuclear Translocation of Heme Oxygenase-1 Confers Resistance to Imatinib in Chronic Myeloid Leukemia Cells. Current Pharmaceutical Design. 19(15). 2765–2770. 78 indexed citations

12.

Romano, Alessandra, Nunziatina Laura Parrinello, Calogero Vetro, et al.. (2013). Myeloid Cells Exert Immunosuppressive Activity and Have Prognostic Value In Hodgkin Lymphoma. Blood. 122(21). 4238–4238. 1 indexed citations

13.

Tibullo, Daniele, Cesarina Giallongo, Ignazio Barbagallo, et al.. (2012). Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells. Blood. 120(21). 5005–5005. 1 indexed citations

14.

Giallongo, Cesarina, Piera La Cava, Daniele Tibullo, et al.. (2011). Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells. European Journal Of Haematology. 86(3). 216–225. 8 indexed citations

15.

Tibullo, Daniele, Ignazio Barbagallo, Cesarina Giallongo, et al.. (2011). Effects of second‐generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors. Hematological Oncology. 30(1). 27–33. 28 indexed citations

16.

Tibullo, Daniele, Cesarina Giallongo, Piera La Cava, et al.. (2009). Effects of imatinib mesylate in osteoblastogenesis. Experimental Hematology. 37(4). 461–468. 39 indexed citations

17.

Palumbo, Giuseppe A., Cesarina Giallongo, Piera La Cava, et al.. (2009). LOW SPARC EXPRESSION IN CML and ITS Upregulation DURING Imatinib TREATMENT.. Blood. 114(22). 4258–4258. 1 indexed citations

18.

Chiarenza, Annalisa, Nunziatina Laura Parrinello, Piera La Cava, et al.. (2009). Lenalidomide IS Able to Restore Immune SYSTEM IN MULTIPLE MYELOMA PATIENTS.. Blood. 114(22). 4909–4909. 2 indexed citations

19.

Parrinello, Nunziatina Laura, Piera La Cava, Daniele Tibullo, et al.. (2009). Myeloid-Derived Suppressor Cells in Patients with Hodgkin Lymphoma.. Blood. 114(22). 3662–3662. 4 indexed citations

20.

Parrinello, Nunziatina Laura, Piera La Cava, Daniele Tibullo, et al.. (2009). Myeloid-Derived Suppressor Cells in Patients with Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance.. Blood. 114(22). 4890–4890. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact